YD Bio (NASDAQ:YDES) Trading Up 11.9% – What’s Next?

YD Bio Limited (NASDAQ:YDES) shares were up 11.9% on Thursday . The stock traded as high as $9.24 and last traded at $9.02. Approximately 2,320 shares were traded during trading, a decline of 95% from the average daily volume of 47,814 shares. The stock had previously closed at $8.06.

Analyst Ratings Changes

YDES has been the topic of a number of analyst reports. Weiss Ratings restated a “sell (d+)” rating on shares of YD Bio in a research note on Monday, December 29th. Wall Street Zen raised shares of YD Bio to a “sell” rating in a research report on Tuesday, November 4th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company presently has a consensus rating of “Sell”.

YD Bio Stock Up 6.5%

The firm’s fifty day moving average price is $11.15.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in YD Bio stock. Geode Capital Management LLC lifted its stake in shares of YD Bio Limited (NASDAQ:YDES) by 10.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 58,363 shares of the biotechnology company’s stock after purchasing an additional 5,292 shares during the quarter. Geode Capital Management LLC owned about 0.08% of YD Bio worth $711,000 at the end of the most recent quarter.

YD Bio Company Profile

YD Bio Limited is a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations.